Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Goodwill & Intangibles (2020 - 2026)

Kamada's (KMDA) quarterly Goodwill & Intangibles came in at $94.0 million in Q2 2026, down 5.69% on a YoY basis from $99.6 million in Q2 2025, and down 1.79% quarter-over-quarter from $95.7 million in Q1 2026.

Analysis

Kamada (KMDA) Goodwill & Intangibles (2020 - 2026) Analysis & Trends

Kamada (KMDA) has reported Goodwill & Intangibles for 7 consecutive years, with $94.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Goodwill & Intangibles fell 5.69% year-over-year to $94.0 million; the trailing twelve-month figure through Jun 2026 stood at $94.0 million (down 5.69% YoY), and the FY2025 full-year result was $97.5 million, down 5.54% from the prior year.
  • Goodwill & Intangibles fell to $94.0 million in Q2 2026 per KMDA's latest filing, from $95.7 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $151.9 million in Q1 2022 and bottomed at $94.0 million in Q2 2026.
  • Historically, Goodwill & Intangibles has averaged $119.5 million across 5 years, with a median of $107.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles jumped 4308.12% in 2022, then dropped 26.51% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $147.1 million in 2022, then dropped by 25.1% to $110.2 million in 2023, then dropped by 6.29% to $103.2 million in 2024, then retreated by 5.54% to $97.5 million in 2025, then slipped by 3.63% to $94.0 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $94.0 million, $95.7 million, and $97.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.97 Mn
Mar 31, 2026 95.68 Mn
Dec 31, 2025 97.51 Mn
Sep 30, 2025 99.19 Mn
Jun 30, 2025 99.64 Mn
Mar 31, 2025 101.42 Mn
Dec 31, 2024 103.23 Mn
Sep 30, 2024 104.73 Mn
Jun 30, 2024 106.52 Mn
Mar 31, 2024 108.31 Mn
Dec 31, 2023 110.15 Mn
Sep 30, 2023 142.50 Mn
Jun 30, 2023 143.99 Mn
Mar 31, 2023 145.31 Mn
Dec 31, 2022 147.07 Mn
Sep 30, 2022 148.62 Mn
Jun 30, 2022 150.45 Mn
Mar 31, 2022 151.86 Mn
Dec 31, 2021 121.17 Mn
Sep 30, 2021 3.38 Mn